Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'25
Mar'24
No of Months
12
12
Operating Income
318.00
368.00
Less :Inter divisional transfers
0.00
0.00
Less: Excise
0.00
0.00
Net Sales
318.00
368.00
Expenditure (Ex Depriciation)
Stock Adjustments
-21.00
9.00
Raw Materials Consumed
188.00
235.00
Power & Fuel Cost
27.00
28.00
Employee Cost
40.00
39.00
Operating Expenses
17.00
12.00
General and Administration Expenses
-1.00
-1.00
Selling and Distribution Expenses
8.00
6.00
Cost of Software developments
0.00
0.00
Miscellaneous Expenses
14.00
12.00
Expenses Capitalised
0.00
0.00
Total Expenditure
282.00
351.00
Operating Profit (PBDIT) excl Other Income
35.00
17.00
Other Income
0.00
0.00
Operating Profit (PBDIT)
36.00
17.00
Interest
14.00
13.00
Profit before Depriciation and Tax
21.00
3.00
Depreciation
16.00
14.00
Profit Before Taxation & Exceptional Items
4.00
-11.00
Exceptional Income / Expenses
0.00
0.00
Profit Before Tax
4.00
-11.00
Provision for Tax
-1.00
-2.00
Profit After Tax
6.00
-9.00
Extraordinary Items
0.00
0.00
Adj to Profit After Tax
0.00
0.00
Profit Balance B/F
86.00
102.00
Profit Available for appropriations
93.00
93.00
Appropriations
93.00
93.00
Equity Dividend (%)
0.00%
0.00%
Earnings Per Share
4.25
-5.73
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is -13.66% vs NA in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 106.13% vs NA in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 7.30% vs NA in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is 174.09% vs NA in Mar 2024
Compare Profit and Loss Results of Mangalam Drugs
Figures in Cr
consolidated - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
318.00
25.00
293.00
1,172.00%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
318.00
25.00
293.00
1,172.00%
Expenditure (Ex Depriciation)
Stock Adjustments
-21.00
0.00
-21.00
0%
Raw Materials Consumed
188.00
10.00
178.00
1,780.00%
Power & Fuel Cost
27.00
1.00
26.00
2,600.00%
Employee Cost
40.00
7.00
33.00
471.43%
Operating Expenses
17.00
0.00
17.00
0%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
8.00
1.00
7.00
700.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
14.00
0.00
14.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
282.00
27.00
255.00
944.44%
Operating Profit (PBDIT) excl Other Income
35.00
-1.00
36.00
3,600.00%
Other Income
0.00
2.00
-2.00
-100.00%
Operating Profit (PBDIT)
36.00
0.00
36.00
0%
Interest
14.00
0.00
14.00
0%
Profit before Depriciation and Tax
21.00
0.00
21.00
0%
Depreciation
16.00
1.00
15.00
1,500.00%
Profit Before Taxation & Exceptional Items
4.00
0.00
4.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
4.00
0.00
4.00
0%
Provision for Tax
-1.00
0.00
-1.00
0%
Profit After Tax
6.00
0.00
6.00
0%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
86.00
61.00
25.00
40.98%
Profit Available for appropriations
93.00
61.00
32.00
52.46%
Appropriations
93.00
61.00
32.00
52.46%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
4.25
-0.46
4.71
1,023.91%
Profit And Loss - Net Sales
Net Sales 318.23 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -13.66% vs NA in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 35.82 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 106.13% vs NA in Mar 2024
Profit And Loss - Interest
Interest 14.93 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 7.30% vs NA in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 6.72 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 174.09% vs NA in Mar 2024






